RT Journal
A1 Mitka M
T1 REsearchers worry about myopathy risk for patients taking high-dose simvastatin
JF JAMA
JO JAMA
YR 2009
FD January 21
VO 301
IS 3
SP 261
OP 262
DO 10.1001/jama.2008.939
UL http://dx.doi.org/10.1001/jama.2008.939
AB 
The negative appraisal of high-dose simvastatin was prompted by new results from the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH), presented at the Scientific Sessions of the American Heart Association held here in November.